John Zajecka to Antipsychotic Agents
This is a "connection" page, showing publications John Zajecka has written about Antipsychotic Agents.
Connection Strength
0.940
-
Oral divalproex sodium loading for adolescent outpatients with acute mania/hypomania: a report of 2 cases. J Clin Psychiatry. 2008 Jun; 69(6):1016-8.
Score: 0.293
-
A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry. 2002 Dec; 63(12):1148-55.
Score: 0.200
-
Does folic acid interfere with lamotrigine? Lancet Psychiatry. 2016 08; 3(8):704-705.
Score: 0.129
-
A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder. J Clin Psychiatry. 2012 Dec; 73(12):1541-7.
Score: 0.100
-
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry. 2003 Jul; 160(7):1263-71.
Score: 0.052
-
Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. J Clin Psychiatry. 2003 Mar; 64(3):288-94.
Score: 0.051
-
Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry. 2001 Jan; 62(1):12-8.
Score: 0.044
-
Pharmacotherapy of depression and mixed states in bipolar disorder. J Affect Disord. 2000 Sep; 59 Suppl 1:S39-S56.
Score: 0.043
-
Management of comorbid anxiety and depression. J Clin Psychiatry. 1995; 56 Suppl 2:10-3.
Score: 0.029